Recombinant antibody fragments and immunotoxin fusions for cancer therapy

In Vivo

Volumn 14, Issue 1, 2000, Pages 21-27

  Brinkmann, Ulrich ^a  

^a Epidauros Biotechnologie AG   (Germany)

Author keywords

Cancer therapy; Immunotoxin fusion; Protein engineering

Indexed keywords

IMMUNOTOXIN; PSEUDOMONAS EXOTOXIN;

APOPTOSIS; CANCER; CANCER IMMUNOTHERAPY; CELL SPECIFICITY; CLINICAL TRIAL; DISEASE MODEL; HUMAN; PROTEIN SYNTHESIS; REVIEW;

EID: 0034109338     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Buchner J and Rudolph R: Renaturation, purification and characterization of recombinant Fab fragments produced in E.coli. Biotechnology 9: 157-162, 1991.
2. Bird RE., Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, Pope SH, Riordan GS and Whitlow M: Single-chain antigen binding proteins. Science 242: 423-426, 1988.
3. Johnson S, and Bird RE.. Construction of single-chain Fv derivatives of monoclonal antibodies and their production in Escherichia coli. Meth Enzymol 203: 88-98, 1991.
4. Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotny J, Margulies MN, Ridge RJ, Bruccoleri RE, Haber EC, Crea R and Oppermann H: Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci USA 85: 5879-5883, 1988.
5. Chaudhary VK, Queen C, Junghans RP, Waldman TA, Fitzgerald DJ and Pastan I: A recombinant immunotoxin consisting of two antibody variable domains fused to pseudomonas exotoxin. Nature 339: 394-397, 1989.
6. Glockshuber R, Malia M, Pfitzinger I, Pluckthun A: A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry 29(6): 1362-7, 1990.
7. Webber KO, Reiter Y, Brinkmann U, Kreitman RJ and Pastan I: Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: Comparison with its single-chain analog Mol Immunol 32: 249-258, 1995.
8. Batra JK, Fitzgerald D, Gately M, Chaudhary VK and Pastan I: Anti-Tac(Fv)-PE40, a single-chain antibody Pseudomonas exotoxin fusion protein directed at interleukin-2 receptor bearing cells. J Biol Chem 265: 15198-15202, 1990.
9. Batra JK, Kasprzyk PG, Bird RE, Pastan I, King CR: Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin. Proc Natl Acad Sci USA 89(13): 5867-71, 1992.
10. Wels W, Harwerth IM, Mueller M, Groner B, Hynes NE: Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Res 52(22): 6310-7, 1992.
11. Reiter Y, Brinkmann U, Jung S-H, Lee B, Kasprzyk PG, King CR and Pastan I: Improved binding and anti tumor activity of a recombinant anti-erbB2 immunotoxin by disulfide-stabilization of the Fv fragment J Biol Chem 269: 18327-18331, 1994.
12. Jung SH, Pastan I, Lee B: Design of interchain disulfide bonds in the framework region of the Fv fragment of the monoclonal antibody B3. Proteins 19(1): 35-47, 1994.
13. Kabat EA, Wu TT, Perry HM, Gottesman KS and Foeller C: Proteins of immunological Interest. US. Dept. Health anh Human Services, Public Health Services, National Institutes of Health. NIH Publication. 5th ed., No. 91-3242, 1991.
14. Brinkmann U, Reiter Y, Jung SH, Lee B and Pastan I: A recombinant immunotoxin containing a disulfide-stabilized Fv fragment. Proc Natl Acad Sci USA 90: 7538-7542, 1993.
15. Reiter Y, Pai LH, Brinkmann U, Wang QC and Pastan I: Antitumor activity in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment. Cancer Research 54: 2714-2718, 1994.
16. Benhar I, Reiter Y, Pai LH, Pastan I: Administration of disulfide-stabilized Fv-immunotoxins B1(dsFv)-PE38 and B3(dsFv)-PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude mice. Int J Cancer 62(3): 351-5, 1995.
17. Reiter Y, Brinkmann U, Kreitman RJ, Jung S-H, Lee B and Pastan I: Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions Biochemistry 33: 5451-5459, 1994.
18. Reiter Y and Pastan I: Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis. Trends Biotechnol 12: 513-520, 1998.
19. Reiter Y, Pai LH, Brinkmann U, Wang QC and Pastan I: Antitumor activity in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment. Cancer Research 54: 2714-2718, 1994.
20. Reiter Y, Brinkmann U, Jung S-H, Lee B and Pastan I: Engineering disulfide bonds into conserved framework regions of Fv fragments: Recombinant Immunotoxins containing disulfide-stabilized Fv with improved biochemical characteristics. Protein Engineering 7: 697-704, 1994
21. Reiter Y, Kurucz I, Brinkmann U, Lee B, Segal DM and Pastan I: Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structure. Immunity 2: 281-287, 1995.
22. Pastan I, Lovelace ET, Gallo M, Rutherford AV, Magnani JL and Willingham MC: Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas. Cancer Res 51: 3781-3787, 1991.
23. Brinkmann U, Pai LH, FitzGerald DJ, Willingham M and Pastan I: B3(Fv)-PE38KDEL, a single chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc Natl Acad Sci USA 88: 8616-8620, 1991.
24. Bera TK, Onda M, Brinkmann U and Pastan I: A bivalent disulfide-stabilized Fv with improved antigen binding to erbB2. J Mol Biol 281: 475-483, 1998.
25. Brinkmann U, DiCarlo A, Vasmatzis G, Kurochkina N, Beers R, Lee, BK and Pastan I: Stabilization of a recombinant Fv fragment by base-loop interconnection and VH-VL permutation. J Mol Biol 268: 107-117, 1997.
26. Malmborg AC, Borrebaeck CA: BIAcore as a tool in antibody engineering. J Immunol Methods 183(1): 7-13, 1995.
27. Rajagopal V, Pastan I and Kreitman RJ: A form of anti-Tac (Fv) which is both single-chain and disulfide-stabilized: comparison with its single-chain and disulfide-stabilized homologs. Protein Eng 10: 1453-1459, 1997.
28. Kobayashi H, Han ES, Kim JS, Le N, Rajagopal V, Kreitman RJ, Pastan I, Paik CH, Carrasquillo JA: Similarities in the biodistribution of iodene-labeled anti-tac single-chain disulfide-stabilized Fv fragment and anti-tac disulfide-stabilized Fv fragment. Nuc Med Biol 25: 387-393, 1998.
29. Studier FW, Rosenberg AH, Dunn JJ and Dubendorff JW: Use of T7 polymerase to direct expression of cloned genes. Meth Enzymol 185: 60-89, 1990.
30. Brinkmann U and Pastan I: Recombinant Immunotoxins: From Basic Research to Cancer Therapy. Methods 8: 143-156, 1995.
31. Brinkmann U: Recombinant Toxins: Protein Engineering for Cancer Therapy Molecular Medicine Today 2, 439-446, 1996.
32. McCafferty J, Griffiths AD, Winter G, Chiswell DJ: Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348(6301): 552-4, 1990.
33. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR: Making antibodies by phage display technology. Annu Rev Immunol 12: 433-5527a, 1994.
34. Brinkmann U, Buchner J and Pastan I: Independent domain folding of Pseudomonas exotoxin and single chain immunotoxins: Influence of interdomain connections. Proc Natl Acad Sci USA 89: 3075-3079, 1992.
35. Rudolph R and Lilie H: In vitro folding of inclusion body proteins FASEB J. 10: 49-56, 1996.
36. Lilie H, Schwarz E and Rudolph R: Advances in refolding of proteins produced in E.coli. Curr Opin Biotechnol 9: 497-501, 1998.
37. Buchner J, Pastan I and Brinkmann U: A method to increase the yield of properly folded recombinant fusion proteins: Single- chain immunotoxins from renaturation of bacterial inclusion bodies. Anal Biochem 205: 263-270, 1992.
38. Reiter Y, Brinkmann U, Lee B and Pastan I: Engineering Antibody Fv Fragments for Cancer Detection and Therapy: Disulfide-Stabilized Fv Fragments. Nature Biotechnol 14: 1239-1245, 1996
39. Vitetta ES: From the basic science of B cells to biological missiles at the bedside. J Immunol 153(4): 1407-20, 1994.
40. Pai LH, Pastan I: Immunotoxins and recombinant toxins for cancer treatment. Important Adv Oncol 3: 1912, 1994.
41. Pastan IH, Archer GE, McLendon RE, Friedman HS, Fuchs HE, Wang QC, Pai LH, Herndon J, Bigner DD: Intrathecal administration of single-chain immunotoxin. LMB-7 [B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model. Proc Natl Acad Sci USA 92(7): 2765-9, 1995.
42. Kreitman RJ and Pastan I: Recombinant single-chain immunotoxins against T and B cell leukemias. Leuk. Lymphoma 13: 1-10, 1994.
43. Keppler-Hafkemeyer A, Brinkmann U and Pastan I: Role of caspases in immunotoxin induced apoptosis of cancer cells. Biochemistry 37: 16934-16942, 1998.
44. Hafkemeyer P, Brinkmann U, Gottesman MM and Pastan I: Apoptosis induced by Pseudomonas Exotoxin: a sensitive and rapid marker for gene delivery in vivo. Hum.Gene Ther 10: 923-934, 1999.
45. Pai LH, Wittes R, Setser A, Willingham MC and Pastan I: Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas Exotoxin Nat Med 3: 350-353, 1996.
46. Pai LH and Pastan I: Clinical trials with pseudomonas exotoxin immunotoxins Curr Topics Mikrobiol Immunol 234: 83-96, 1998.
47. Kreitman RJ and Pastan I. Targeting Pseudomonas exotoxin to hematologic malignancies. Cancer Biol 6: 297-306, 1995.
48. Kreitman RJ, Wilson WH, White JD, Stetler-Stevenson M, Jaffe E, Waldman TA, and Pastan I: Phase 1 trial of recombinant immunotoxin anti-tac(Fv)-PE38 (LMB2) in patients with hematologic malignancies. J Clin Oncol 1999 in press
49. Kreitman RJ, Wilson WH, Robbins D, Margulies I, Stetler-Stevenson M, Waldman TA and Pastan I: Responses in refractory hairy cell leukemia to a recombinant immunotoxin. Blood 1999 in press
50. Brinkmann U and Pastan I: Immunotoxins against cancer. Biochim Biophys Acta 1198(1): 27-45, 1994.
51. Allured VS, Collier RJ, Carroll SF, McKay DB Structure of exotoxin A of Pseudomonas aeruginosa at 30-Angstrom resolution. Proc Natl Acad Sci USA 83(5): 1320-4, 1986.
52. Hwang J, Fitzgerald DJ, Adhya S, Pastan I: Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell 48(1): 129-36, 1987.
53. Kounnas MZ, Morris RE, Thompson MR, FitzGerald DJ, Strickland DK, Saelinger CB: The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J Biol Chem 267(18): 12420-3, 1992.
54. Batra JK, Jinno Y, Chaudhary VK, Kondo T, Willingham MC, FitzGerald DJ, Pastan I Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin. Proc Natl Acad Sci USA 86(21): 8545-9, 1989.